Evidence map›Paper›PMID 37713166›Full record

ArticleJournal of racial and ethnic health disparities2024

Healthcare Experiences of African American Women with the Fragile X Premutation.

Andrew P King, Nadia Ali, Cecelia Bellcross, Fabienne Ehivet, Heather S Hipp, Jessica Vaughn, Emily G Allen

Open access · hybridAbstract read
In one paragraph

Article in Journal of racial and ethnic health disparities, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Andrew P KingDepartment of Human Genetics, Emory University School of Medicine, Atlanta, GA, USA.
Nadia AliDepartment of Human Genetics, Emory University School of Medicine, Atlanta, GA, USA.
Cecelia BellcrossDepartment of Human Genetics, Emory University School of Medicine, Atlanta, GA, USA.ORCID 0000-0002-5974-0172
Fabienne EhivetDepartment of Human Genetics, Emory Healthcare, Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA, USA.
Heather S HippDivision of Reproductive Endocrinology and Infertility, Department of Gynecology and Obstetrics, Emory University School of Medicine, Atlanta, GA, USA.ORCID 0000-0002-1089-3928
Jessica VaughnGeneScreen Counseling, Morristown, NJ, USA.
Emily G AllenDepartment of Human Genetics, Emory University School of Medicine, Atlanta, GA, USA. emily.g.allen@emory.edu.ORCID 0000-0003-0963-036X
Emory University · USEmory Healthcare · USScreen · US

Funding

Recruitment CoreU54NS091859 · NINDS · EMORY UNIVERSITY · PI WARREN, STEPHEN T. · 2014 to 2019
$9.1M
The FMR1 CGG repeat as functional element and therapeutic target in Fragile X associated disordersP50HD104463 · NICHD · BAYLOR COLLEGE OF MEDICINE · PI NELSON, DAVID LOREN, TODD, PETER K · 2020 to 2024
$9.0M
NICHD NIH HHS P50 HD104463NINDS NIH HHS U54 NS091859
6 · The paper itself

Abstract

This study aims to understand the healthcare experiences of African American women with a fragile X premutation (PM). PM carriers are at risk for fragile X-associated conditions, including primary ovarian insufficiency (FXPOI) and neuropsychiatric disorders (FXAND). There is no racial/ethnic association with carrying a PM, but African American women historically experience barriers receiving quality healthcare in the USA. Obstacles to care may increase mental health conditions like anxiety and depression. Eight African American women with a PM were interviewed to explore disparities in receiving healthcare and to learn about psychosocial experiences during and after their diagnoses. Interviews were transcribed verbatim and independently coded by two researchers. A deductive-inductive approach was used, followed by thematic analysis to determine prominent themes. The average participant age was 52.3 ± 8.60 years, with a mean age at premutation diagnosis of 31 ± 5.95 years. Seven participants had children with FXS. Themes from interviews included healthcare experiences, family dynamics, and emotional/mental health after their diagnosis. Participants reported concerns about not being taken seriously by providers and mistrust of the medical institutions. Within families, participants reported denial, insensitivity, and isolation. Participants reported a high incidence of anxiety and depression. Both are symptoms of FXAND and stresses of systemic racism and sexism. The reported family dynamics around the news of a genetic diagnosis stand apart from other racial cohorts in fragile X research: interventions like family counseling sessions and inclusive support opportunities from national organizations could ease the impacts of a PM for African American women.

Indexed as

Black or African AmericanFragile X SyndromeAdultFemaleFragile X Messenger Ribonucleoprotein 1Healthcare DisparitiesHumansMiddle AgedQualitative ResearchUnited StatesFragile X Messenger Ribonucleoprotein 1African AmericanFragile XFXPOIPremutationRaceWomen

Identifiers

PMID37713166
PMCPMC11086630
OpenAlexW4386757006

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.